Comparison of International Ovarian Tumor Analysis Simple Rules with Risk of Malignancy Index for Preoperative Differentiation of Benign and Malignant Adnexal Masses
M Manodarshni, P Pallavee
Keywords :
Adnexal masses, International Ovarian Tumor Analysis, Risk of malignancy index, Ultrasonography
Citation Information :
Manodarshni M, Pallavee P. Comparison of International Ovarian Tumor Analysis Simple Rules with Risk of Malignancy Index for Preoperative Differentiation of Benign and Malignant Adnexal Masses. J South Asian Feder Obs Gynae 2023; 15 (3):321-325.
Introduction: Precise risk assessment of adnexal masses preoperatively is important for early diagnosis and better prognosis of ovarian malignancy. Although, there are many models for the prediction of ovarian malignancy, risk of malignancy index-1 (RMI-1) and International Ovarian Tumor Analysis-Simple Rules (IOTA-SR) are the most used. The aim of our study was to compare the diagnostic accuracy of IOTA-SR with RMI-1 for preoperative differentiation of benign and malignant adnexal masses.
Materials and methods: A total of 121 women with adnexal masses, planned for surgery were enrolled in the study. Serum CA-125 was done, and an ultrasound examination was performed at the time of preoperative assessment by consultants. RMI-1 score of more than 200 was the cut-off value used to denote malignancy. IOTA-SR was applied to find the nature of the mass. Based on the histopathology report the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. The diagnostic accuracy of RMI-1 and IOTA-SR were compared.
Results: The study included 121 adnexal masses, out of which 110 (90.9%) were benign, 8 (6.6%) were malignant and 3 (2.5%) were borderline ovarian tumors. About 22.3% of the cases were found to be inconclusive by IOTA-SR. Sensitivity, specificity, PPV, and NPV of RMI-1 were 63.6, 100, 100, and 96.4%, respectively, whereas that of IOTA-SR was 100, 96.4, 73.3, and 100%, respectively. The diagnostic accuracy of IOTA-SR was better than RMI-1 (AUC = 0.98 vs 0.87).
Conclusion: The model, IOTA-SR, for the prediction of ovarian malignancy, has better diagnostic accuracy and higher sensitivity when compared to RMI-1 in preoperative discrimination of benign and malignant adnexal mass.
Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound, and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97(10):922–929. DOI: 10.1111/j.1471-0528.1990.tb02448.x.
Westwood M, Ramaekers B, Lang S, et al. Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: A systematic review and cost-effectiveness analysis. Health Technol Assess 2018;22(44):1–264. DOI: 10.3310/hta22440.
Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 2016;214(4):424–437. DOI: 10.1016/j.ajog.2016.01.007.
Bhagde AD, Jani SK, Patel MS, et al. An analytical study of 50 women presenting with an adnexal mass. Int J Reprod Contracept Obstet Gynecol 2016;6(1):262. DOI: 10.18203/2320-1770.ijrcog20164671.
Fathallah K, Huchon C, Bats AS, et al. External validation of simple ultrasound rules of Timmerman on 122 ovarian tumors. Gynecol Obstet Fertil 2011;39(9):477–481. DOI: 10.1016/j.gyobfe.2011.05.007.
Auekitrungrueng R, Tinnangwattana D, Tantipalakorn C, et al. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses. Int J Gynecol Obstet 2019;146(3):364–369. DOI: 10.1002/ijgo.12891.
Sayasneh A, Wynants L, Preisler J, et al. Multicentre external validation of IOTA prediction models and RMI by operators with varied training. Br J Cancer 2013;108(12):2448–2454. DOI: 10.1038/bjc.2013.224.
Garg S, Kaur A, Mohi JK, et al. Evaluation of IOTA simple ultrasound rules to distinguish benign and malignant ovarian tumours. J Clin Diagn Res 2017;11(8):TC06–TC09. DOI: 10.7860/JCDR/2017/26790.10353.
Tinnangwattana D, Vichak–Ururote L, Tontivuthikul P, et al. IOTA simple rules in differentiating between benign and malignant adnexal masses by non-expert examiners. Asian Pac J Cancer Prev 2015;16(9):3835–3838. DOI: 10.7314/apjcp.2015.16.9.3835.
Avesani G, Caliolo G, Gui B, et al. Pearls and potential pitfalls for correct diagnosis of ovarian cystadenofibroma in MRI: A pictorial essay. Korean J Radiol 2021;22(11):1809–1821. DOI: 10.3348/kjr.2020.1312.
Meys E, Kaijser J, Kruitwagen R, et al. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Eur J Cancer 2016;58:17–29. DOI: 10.1016/j.ejca.2016.01.007.
Ning C, Ji X, Wang H, et al. Association between the sonographer's experience and diagnostic performance of IOTA simple rules. World J Surg Oncol 2018;16(1):179. DOI: 10.1186/s12957-018-1479-2.
Nunes N, Ambler G, Foo X, et al. Use of IOTA simple rules for diagnosis of ovarian cancer: Meta-analysis. Ultrasound Obstet Gynecol 2014;44(5):503–514. DOI: 10.1002/uog.13437.